Codexis, Inc. Advances RNA Manufacturing with 50g siRNA Production Agreement for Cardiovascular Program

Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing,  announced it has ent...

March 06, 2026 | Friday | News
Cipla USA Inc. Launches Generic Saxenda® in the U.S., Expanding Access to GLP-1 Weight Management Therapy

Cipla USA Inc. the wholly owned subsidiary of Cipla Limited(BSE: 500087; NSE: CIPLA; and hereafter referred to as "Cipla")announced the launch of Li...

March 03, 2026 | Tuesday | News
Innovent Biologics, Inc. Announces NMPA Approval of Jaypirca® for CLL/SLL in China

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality...

March 03, 2026 | Tuesday | News
Illumina, Inc. Showcases Oncology Breakthroughs Powered by Integrated Multiomics Platform

Illumina, Inc. announced new customer breakthroughs in oncology powered by Illumina's spatial transcriptomics, 5-base sequencing, and proteomics technolo...

February 27, 2026 | Friday | News
Nexus Precision Health Acquires Leal Health to Build Scalable, AI-Driven Precision Medicine Network

  Combined platform connects 250,000+ patients, 40,000+ clinicians, and 90+ biopharma partners—creating a real-world network for precision medi...

February 27, 2026 | Friday | News
Johnson & Johnson Files for FDA Approval of IMAAVY® in Warm Autoimmune Hemolytic Anemia

Johnson & Johnson announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA), see...

March 26, 2026 | Thursday | News
Abbott Secures Shareholder Approval for Exact Sciences Acquisition in Major Diagnostics Expansion

Exact Sciences Corporation (NASDAQ: EXAS) (“Exact Sciences”), a leading provider of cancer screening and diagnostic tests,  announced th...

February 24, 2026 | Tuesday | News
Alto Neuroscience, Inc. Completes Patient Enrollment in Phase 2 Trial of ALTO-101 for Schizophrenia-Related Cognitive Impairment

-Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision medi...

February 16, 2026 | Monday | News
Neupulse Secures £3 Million Backing to Accelerate Non-Drug Treatment for Tourette Syndrome

Funding led by Eos Advisory and Midlands Engine Investment Fund II, through appointed fund  manager Mercia Ventures, signals strong investor confidenc...

February 16, 2026 | Monday | News
Wellumio Raises $7.28 Million to Advance Portable MRI Technology for Rapid Stroke Diagnosis

Wellumio, a New Zealand-based medical technology company developing a portable neuroimaging device for rapid, point-of-care stroke detection, has raised $7...

February 12, 2026 | Thursday | News
MerryLife Advances Multi-Pathway Alzheimer’s Therapy TML-6 Following Positive Phase 1 Data

MerryLife Biomedical Inc., a clinical-stage biotechnology company focused on neurodegenerative diseases, announced positive Phase 1 results for TML-6, it...

February 11, 2026 | Wednesday | News
Median Technologies Secures FDA Clearance for AI Powered eyonis LCS Lung Cancer Screening Software

eyonis® LCS aims to redefine lung cancer screening by supporting diagnosis at early, curable stages, while reducing false positives to avoid unne...

February 10, 2026 | Tuesday | News
Peijia Medical Advances Global Expansion with EU MDR CE Mark Filing for GeminiOne TEER System

Peijia Medical Limited announced that it has formally submitted the European Union Medical Device Regulation (EU MDR) CE Mark registration application fo...

February 10, 2026 | Tuesday | News
Aminex Launches Mid-Stage Trial of Polyamine-Targeting Therapy in Solid Tumors

Novel approach attacks production of polyamines that tumors require to proliferate and suppress the immune system  Aminex Therapeutics, Inc., a...

February 06, 2026 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close